EGIS-12,233

EGIS-12,233
Clinical data
ATC code	none;
Identifiers
	IUPAC name 5,7-dichloro-3-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-indolin-2-one;
PubChem CID	11525867;
ChemSpider	9700653;
ChEMBL	ChEMBL260870;
CompTox Dashboard (EPA)	DTXSID501028191 ;
Chemical and physical data
Formula	C24H28Cl3N3O
Molar mass	480.86 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c3cc(Cl)ccc3N4CCN(CC4)CCCCC1(CC)c2cc(Cl)cc(Cl)c2NC1=O;
	InChI InChI=1S/C24H28Cl3N3O/c1-2-24(20-15-18(26)16-21(27)22(20)28-23(24)31)9-3-4-10-29-11-13-30(14-12-29)19-7-5-17(25)6-8-19/h5-8,15-16H,2-4,9-14H2,1H3,(H,28,31); Key:NOWFIMHNXPZVSK-UHFFFAOYSA-N;
	(verify)

EGIS-12,233 is a drug with applications in scientific research, acting as a potent and selective antagonist for both the 5-HT₆ and 5-HT₇ serotonin receptor subtypes, with good selectivity over other receptors.^[1] It has been shown to increase dopamine release in cochlear tissue, suggesting a role for the 5-HT₆ and 5-HT₇ receptors in regulation of the hearing system.^[2]

References

^ Volk B, Barkóczy J, Hegedus E, Udvari S, Gacsályi I, Mezei T, et al. (April 2008). "(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists". Journal of Medicinal Chemistry. 51 (8): 2522–32. doi:10.1021/jm070279v. PMID 18361484.2522-32&rft.date=2008-04&rft_id=info:doi/10.1021/jm070279v&rft_id=info:pmid/18361484&rft.aulast=Volk&rft.aufirst=B&rft.au=Barkóczy, J&rft.au=Hegedus, E&rft.au=Udvari, S&rft.au=Gacsályi, I&rft.au=Mezei, T&rft.au=Pallagi, K&rft.au=Kompagne, H&rft.au=Lévay, G&rft.au=Egyed, A&rft.au=Hársing, LG&rft.au=Spedding, M&rft.au=Simig, G&rfr_id=info:sid/en.wikipedia.org:EGIS-12,233" class="Z3988">
^ Doleviczényi Z, Vizi ES, Gacsályi I, Pallagi K, Volk B, Hársing LG, et al. (November 2008). "5-HT6/7 receptor antagonists facilitate dopamine release in the cochlea via a GABAergic disinhibitory mechanism". Neurochemical Research. 33 (11): 2364–72. doi:10.1007/s11064-008-9796-4. PMID 18663573. S2CID 11148455.2364-72&rft.date=2008-11&rft_id=https://api.semanticscholar.org/CorpusID:11148455#id-name=S2CID&rft_id=info:pmid/18663573&rft_id=info:doi/10.1007/s11064-008-9796-4&rft.aulast=Doleviczényi&rft.aufirst=Z&rft.au=Vizi, ES&rft.au=Gacsályi, I&rft.au=Pallagi, K&rft.au=Volk, B&rft.au=Hársing, LG&rft.au=Halmos, G&rft.au=Lendvai, B&rft.au=Zelles, T&rfr_id=info:sid/en.wikipedia.org:EGIS-12,233" class="Z3988">

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Clinical data

ATC code	none
Identifiers
IUPAC name 5,7-dichloro-3-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-indolin-2-one
PubChem CID	11525867
ChemSpider	9700653
ChEMBL	ChEMBL260870
CompTox Dashboard (EPA)	DTXSID501028191
Chemical and physical data
Formula	C₂₄H₂₈Cl₃N₃O
Molar mass	480.86 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES c3cc(Cl)ccc3N4CCN(CC4)CCCCC1(CC)c2cc(Cl)cc(Cl)c2NC1=O
InChI InChI=1S/C24H28Cl3N3O/c1-2-24(20-15-18(26)16-21(27)22(20)28-23(24)31)9-3-4-10-29-11-13-30(14-12-29)19-7-5-17(25)6-8-19/h5-8,15-16H,2-4,9-14H2,1H3,(H,28,31) Key:NOWFIMHNXPZVSK-UHFFFAOYSA-N
(verify)